Stock listing

Lakefront Biotherapeutics

Selected listing: A0YGNJ · LS · EUR · DE

Lakefront Biotherapeutics (Lang & Schwarz: A0YGNJ), Health Technology. Latest release Sep 8, 2026: Lakefront to Present at the Morgan Stanley 24th Annual…

A0YGNJ:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A0YGNJ
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Lakefront Biotherapeutics

Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

September 8, 2026

Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update

August 10, 2026

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

July 13, 2026

Acquisition of Own Shares

June 30, 2026

Lakefront Biotherapeutics NV - Acquisition of Own Shares

June 17, 2026

All Lakefront Biotherapeutics news →

Research Lakefront Biotherapeutics

Lakefront Biotherapeutics company profile

View the public company page for Lakefront Biotherapeutics on 6ix.

Lakefront Biotherapeutics news

Read company news and market updates connected to Lakefront Biotherapeutics.

Lakefront Biotherapeutics investor events

Find investor webinars, events, and replay context for Lakefront Biotherapeutics.